Qube Research & Technologies (QRT)
CTKB icon

Qube Research & Technologies (QRT)’s Cytek Biosciences CTKB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
+689,821
New +$2.94M ﹤0.01% 1894
2025
Q2 		– Sell
-19,573
Closed -$78.5K – 3600
2025
Q1 		$78.5K Buy
+19,573
New +$101K ﹤0.01% 3039
2023
Q2 		– Sell
-128,574
Closed -$1.18M – 2486
2023
Q1 		$1.18M Buy
128,574
+17,026
+15% +$183K 0.01% 1222
2022
Q4 		$1.14M Buy
+111,548
New +$1.5M 0.01% 1172

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CTKB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 689,821 shares worth $3.06M. The stake represents ﹤0.01% of the portfolio and ranks #1894 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in CTKB as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in CTKB in Q4 2022 and has held it in 4 quarters since. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Qube Research & Technologies (QRT) held 689,821 shares of Cytek Biosciences worth $3.06M as of Q2 2026.
  • Cytek Biosciences was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1894 holding.
  • Qube Research & Technologies (QRT) first reported a position in Cytek Biosciences in Q4 2022 and has held it in 4 quarters since.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.